Hims & Hers Health (NYSE:HIMS) Price Target Cut to $40.00 by Analysts at Morgan Stanley
Hims & Hers Health (NYSE:HIMS – Get Free Report) had its price objective dropped by stock analysts at Morgan Stanley from $60.00 to $40.00 in a report released on Tuesday,Benzinga reports. The firm presently has an “equal weight” rating on the stock. Morgan Stanley’s target price indicates a potential upside of 20.99% from the company’s […]
Hims & Hers Health (NYSE:HIMS – Get Free Report) had its price objective dropped by stock analysts at Morgan Stanley from $60.00 to $40.00 in a report released on Tuesday,Benzinga reports. The firm presently has an “equal weight” rating on the stock. Morgan Stanley’s target price indicates a potential upside of 20.99% from the company’s […]
